Insiders iTeos Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
17.44 ^USD	+43.07%		+49.57%	+59.27%

06:31pm	Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating	MT
03:45pm	ITeos Therapeutics Q1 Net Loss Widens; Initiates $120 Million Registered Direct Offering -- Shares Jump	MT

ITeos Therapeutics, Inc. Appoints Jill DeSimone to its Board of Directors, Effective March 7, 2024	03-06	CI
Iteos Therapeutics, Inc. Announces Board Changes	12-07	CI
ITeos Therapeutics, Inc. Announces Resignation of Joanne Jenkins Lager as Chief Medical Officer	23-06-26	CI
ITeos Therapeutics, Inc. Announces Resignation of Detlev Biniszkiewicz as Member of the Board of Directors	23-06-20	CI
ITeos Therapeutics, Inc. Announces Resignation of Matthew Roden from the Board	23-02-03	CI
Insider Sell: Iteos Therapeutics	22-05-12	MT
Insider Sell: iTeos Therapeutics	22-05-03	MT
Insider Buy: iTeos Therapeutics	22-03-25	MT
ITeos Therapeutics, Inc. Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer	22-01-10	CI
Insider Sell: Iteos Therapeutics	22-01-07	MT
Insider Sell: Iteos Therapeutics	22-01-06	MT
Insider Sell: Iteos Therapeutics	21-12-08	MT
Insider Sell: Iteos Therapeutics	21-12-03	MT
Insider Sell: Iteos Therapeutics	21-11-26	MT
Insider Sell: Iteos Therapeutics	21-10-18	MT
Insider Sell: Iteos Therapeutics	21-10-14	MT
Insider Sell: Iteos Therapeutics	21-10-12	MT
Insider Sell: Iteos Therapeutics	21-10-05	MT
Insider Sell: Iteos Therapeutics	21-09-28	MT
Insider Sell: Iteos Therapeutics	21-09-23	MT

No results for this search